Good MorningEquity markets increased last week after solid reports from big tech names Microsoft, Meta Platforms, and Amazon, and favorable economic data, including the PCE price index and the NFP report. The big tech reports reveal solid spending for AI across verticals, while the economic data shows solid job gains and cooling inflation. The S&P 500 would move higher in this scenario if not for the tariff threat, which has yet to be fully realized.
The impact of tariffs on Q1 results is in the guidance. The guidance for most S&P 500 companies has been trimmed, and there is a risk that the outlook could continue to weaken. However, due to the uncertainty regarding trade and tariffs, there is as much risk of a catalyst for a rally emerging as one for selling. The takeaway for investors and traders is to be cautious and prepared for anything to happen in the week ahead. Featured: The options guide that actually starts at the beginning (Ad) 
|
Technology | |
Western Digital Corporation (NASDAQ: WDC) captured investor attention following its fiscal third-quarter 2025 earnings announcement on April 30th, not just for beating profit expectations but also for issuing positive forward guidance that surpassed Western Digital’s analyst community&rs... Read the Full Story |
|
|
Consumer Discretionary | |
Wingstop Inc. (NASDAQ: WING) recently released its first-quarter 2025 financial results, which triggered a positive reaction from the market. Shares jumped on April 30, immediately following the release, as investors digested a potent mix of better-than-expected profitability and accelerating gl... Read the Full Story |
|
Energy | |
Sometimes, the market experiences a new turn of events, creating opportunities for investors who know what to watch out for in their market scans. Of course, these plays only become obvious when it is too late to act upon them. Today, it seems that the opportunity is spread out across a multi-year... Read the Full Story |
|
From Our Partners | | More than 25 candidates were screened for share price between $1 and $5, market cap above $100 million, daily volume over 500,000 shares, and over $10 million in trailing revenue.
Only five stocks cleared every filter, spanning five different sectors. Two are profitable today, and one pays a substantial dividend.
The report also flags what could go wrong with each pick, including dilution and convertible debt. | | See the five stocks that survived this strict revenue screen |
|
Industrials | |
United Parcel Service (NYSE: UPS) stock was trading at deep value levels, offering investors the second, generational buying opportunity in five years, which was confirmed by the Q1 results. The results show that market fears for the quarter, while justified, were unfounded. The Q1/Q2 price correc... Read the Full Story |
|
Technology | |
When the financial markets try to send investors a message, it is very rarely done straightforwardly. Instead of letting everyone know that the path forward is higher or lower, hidden messages start to show up everywhere else, to be decrypted by only those investors who know what they’re l... Read the Full Story |
|
From Our Partners | | Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone.
A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful. | | See the 7 stocks on the watchlist while it's still free |
|
Technology | |
It has been a rough start to the year for the tech sector, as companies have been hit hard by tariffs, trade tensions with China that have axed the flow of essential rare earth metals to the United States, and more. The benchmark Technology Select Sector SPDR Fund (NYSEARCA: XLK), a broad proxy fo... Read the Full Story |
|
Finance | |
Visa Inc. (NYSE: V) recently released its fiscal second-quarter 2025 earnings, exceeding analyst predictions and demonstrating strong operational performance through resilient transaction volumes. Alongside these positive results, the company's Board of Directors authorized a significant new $30... Read the Full Story |
|
Communication Services | |
Shareholders in Meta Platforms (NASDAQ: META), one of the renowned Magnificent Seven stocks, just got a bout of good news. Meta’s Apr. 30 earnings impressed markets, resulting in shares rising over 4% the day after. Due to Microsoft’s (NASDAQ: MSFT) arguably more impressive earnings,... Read the Full Story |
|
Consumer Discretionary | |
Amazon.com Inc. (NASDAQ: AMZN) reported a strong first quarter after Thursday’s close, with results that came in ahead of expectations across all headline metrics. Revenue rose nearly 9% year over year to $155.7 billion, beating by $580 million, while GAAP EPS of $1.59 beat by $0.23.
Yet ... Read the Full Story |
|
Technology | |
Palantir Technologies Inc. (NASDAQ: PLTR) will report earnings after the market closes on May 5. This will be one of the most closely watched earnings reports for bulls and bears alike. And each group of investors will be looking for reasons to support their case.
If you’re bullish on Palan... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey. | | View Today's Stock Pick |
|
